EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Autoimmune Gastritis on Occurrence of Metachronous Gastric Neoplasms after Endoscopic Resection for Gastric Neoplasms

Donghoon Kang iD, Chul-Hyun Lim iD, Jin Su Kim, Yu Kyung Cho iD, Jae Myung Park, Myung-Gyu Choi

Cancers · 05.10.2023 · 15 (19) · 4859

DOI: 10.3390/cancers15194859 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 05.10.2023. Verfasst von Donghoon Kang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul 06591, Republic of Korea. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer is the fifth most common cancer and the third leading cause of cancer-related deaths worldwide. Autoimmune gastritis (AIG) is characterized by antibody production against the gastric parietal cells, reducing the number of functional parietal cells. It is also associated with an increased susceptibility to gastric neuroendocrine tumors and gastric cancer. Endoscopic resection (ER) is an effective treatment for early gastric cancer; however, metachronous gastric neoplasms (MGN) can develop. This study aimed to evaluate the clinical effect of AIG on the occurrence of MGN after ER for gastric neoplasms. We retrospectively analyzed patients who underwent ER for gastric neoplasms. Patients with multiple lesions, recurrent lesions, or a history of partial gastrectomy were excluded. The presence of AIG was determined using anti-parietal cell antibody (APCA) testing. Follow-up endoscopy and metachronous tumor occurrence rates were compared between the AIG and non-AIG groups. Of the 569 patients, 282 underwent APCA testing and 20 (7.1%) were diagnosed with AIG. The incidence of MGN was significantly higher in the AIG group than in the non-AIG group (45.0% vs. 18.3%); however, the MGN occurrence pattern was similar between the two groups. Multivariate analysis revealed that AIG (HR 3.32, 95% CI 1.55–7.10, p = 0.002) and a higher body mass index (HR 1.16, 95% CI 1.06–1.27, p = 0.002) were independent factors significantly associated with the occurrence of MGN. Patients with AIG have a higher risk of metachronous lesion occurrence after ER for gastric neoplasms. Positive results of APCA testing have independent clinical implications for predicting MGN. Proper monitoring and management are essential for early detection and treatment of recurrent lesions in patients with AIG.

Schlagwörter

Stichwörter der Autor:innen

anti-parietal cell antibodyautoimmune gastritisendoscopic resectiongastric cancermetachronous gastric neoplasms

Autor:innen und Institutionen

  • Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul 06591, Republic of Korea.

ORCID-Profile: Donghoon Kang, Chul-Hyun Lim, Yu Kyung Cho

Zitieren

APA

Kang, D., Lim, C. H., Kim, J. S., Cho, Y. K., Park, J. M., & Choi, M. G. (2023). Impact of Autoimmune Gastritis on Occurrence of Metachronous Gastric Neoplasms after Endoscopic Resection for Gastric Neoplasms. Cancers, 15(19), 4859. https://doi.org/10.3390/cancers15194859

Vancouver

Kang D, Lim CH, Kim JS, Cho YK, Park JM, Choi MG. Impact of Autoimmune Gastritis on Occurrence of Metachronous Gastric Neoplasms after Endoscopic Resection for Gastric Neoplasms. Cancers. 2023;15(19):4859. doi:10.3390/cancers15194859

BibTeX
@article{Kang2023,
  author = {Kang, Donghoon and Lim, Chul-Hyun and Kim, Jin Su and Cho, Yu Kyung and Park, Jae Myung and Choi, Myung-Gyu},
  title = {Impact of Autoimmune Gastritis on Occurrence of Metachronous Gastric Neoplasms after Endoscopic Resection for Gastric Neoplasms},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {19},
  pages = {4859},
  doi = {10.3390/cancers15194859}
}
Kostenlos starten →